Literature DB >> 1320328

Adverse effects of neutrophils on the lung.

J E Gadek1.   

Abstract

Studies of both emphysema and adult respiratory distress syndrome (ARDS) support the premise that lung injury is due to unregulated host defense mechanisms. A major mediator of host defense and injury is the neutrophil, which is relatively incapable of regulating its own function. Accordingly, defects in regulatory mechanisms allow neutrophils to damage the lungs. Emphysema serves as a prime example of this link between host defense and injury. Hereditary emphysema is caused by a deficiency in alpha 1-antitrypsin (alpha 1-AT), a protease inhibitor. The decreased levels of this enzyme in affected individuals result in inadequate protection against neutrophil elastase and other proteolytic enzymes, leading to lung damage. Patients with acquired emphysema, associated with cigarette smoking, have normal levels of alpha 1-AT in their lungs. However, the alpha 1-AT in these patients has a reduced ability to associate with and inhibit the action of neutrophil elastase. Thus, both types of emphysema involve an alteration in the balance between proteases and antiproteases. The lung damage observed in patients with ARDS also appears to involve neutrophils, but in this case elastase may not be the culprit. In these patients, neutrophil elastase appears to be inactivated by high levels of alpha 1-AT, thus preventing excess protease action. It is hoped that a more complete understanding of the mechanisms involved in host defense and injury will enable the development of specific therapeutic interventions, such as the alpha 1-AT replacement therapy that is being used to treat patients with hereditary emphysema.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1320328     DOI: 10.1016/0002-9343(92)90604-a

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  7 in total

1.  The Influenza Virus Protein PB1-F2 Increases Viral Pathogenesis through Neutrophil Recruitment and NK Cells Inhibition.

Authors:  Aurore Vidy; Pauline Maisonnasse; Bruno Da Costa; Bernard Delmas; Christophe Chevalier; Ronan Le Goffic
Journal:  PLoS One       Date:  2016-10-31       Impact factor: 3.240

2.  Isolation and properties of stachyrase A, a chymotrypsin-like serine proteinase from Stachybotrys chartarum.

Authors:  Tomasz Kordula; Agnieszka Banbula; Jeremy Macomson; James Travis
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

3.  Quantification of pulmonary uptake of indium-111 labelled granulocytes in inflammatory bowel disease.

Authors:  W Y Ussov; A M Peters; H J Hodgson; J M Hughes
Journal:  Eur J Nucl Med       Date:  1994-01

4.  Pathogenesis of pneumococcal pneumonia in cyclophosphamide-induced leukopenia in mice.

Authors:  Erjian Wang; Marie Simard; Nathalie Ouellet; Yves Bergeron; Denis Beauchamp; Michel G Bergeron
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

5.  Anti-KC autoantibody:KC complexes cause severe lung inflammation in mice via IgG receptors.

Authors:  Agnieszka Krupa; Maria J Walencka; Vivek Shrivastava; Tameka Loyd; Rafal Fudala; Charles W Frevert; Thomas R Martin; Anna K Kurdowska
Journal:  Am J Respir Cell Mol Biol       Date:  2007-06-21       Impact factor: 6.914

Review 6.  Should patients with acute exacerbation of chronic bronchitis be treated with antibiotics? Advantages of the use of fluoroquinolones.

Authors:  J Mensa; A Trilla
Journal:  Clin Microbiol Infect       Date:  2006-05       Impact factor: 8.067

7.  The development of hyperbaric oxygen therapy for skin rejuvenation and treatment of photoaging.

Authors:  Bralipisut Asadamongkol; John H Zhang
Journal:  Med Gas Res       Date:  2014-04-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.